Metabolic genes in cancer: their roles in tumor progression and clinical implications
about
The crystal structure of human transketolase and new insights into its mode of actionEmerging Roles for Maf1 beyond the Regulation of RNA Polymerase III ActivityBroad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and LipogenesisSIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferationDifferential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinomaControllability in cancer metabolic networks according to drug targets as driver nodesFrom obesity to cancer: a review on proposed mechanisms.Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast CancerIntegrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasmsMACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression.Lysophosphatidic acid acyltransferase β (LPAATβ) promotes the tumor growth of human osteosarcoma.Up-regulated FASN expression promotes transcoelomic metastasis of ovarian cancer cell through epithelial-mesenchymal transitionSterol regulatory element-binding protein (SREBP)-1-mediated lipogenesis is involved in cell senescence.Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance.Subcutaneous adipocytes promote melanoma cell growth by activating the Akt signaling pathway: role of palmitic acidHigh expression of ribonucleotide reductase subunit M2 correlates with poor prognosis of hepatocellular carcinoma.SCD1 Expression is dispensable for hepatocarcinogenesis induced by AKT and Ras oncogenes in mice.Epigenetic Silencing of ALDH1L1, a Metabolic Regulator of Cellular Proliferation, in Cancers.Prognostic relevance of acquired uniparental disomy in serous ovarian cancer.Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.Signalling mechanisms regulating phenotypic changes in breast cancer cells.Targeting Intracellular Cholesterol is a Novel Therapeutic Strategy for Cancer Treatment.Maf1 is a novel target of PTEN and PI3K signaling that negatively regulates oncogenesis and lipid metabolismCaffeine inhibits glucose transport by binding at the GLUT1 nucleotide-binding site.Ribonucleotide reductase subunit M2 predicts survival in subgroups of patients with non-small cell lung carcinoma: effects of gender and smoking statusMycoplasmas and cancer: focus on nucleoside metabolismRegulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities.Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatmentDifferentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.Statins impair glucose uptake in tumor cellsPharmGKB summary: very important pharmacogene information for G6PD.Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease.Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase.Dysregulated lipid metabolism in cancer.p53R2 expression as a prognostic biomarker in early stage non-small cell lung cancerOncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples.The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathwaysTemporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response.
P2860
Q24293324-91F2FF21-B16C-4413-8A95-A3CC3C751CDEQ26779562-039EEA26-31ED-42D8-B007-6D2BB5CDD862Q28118739-FE010606-2726-4D29-A162-5FBF01F01A0CQ28278236-1EF943AC-1164-4174-8309-341501602FAFQ28481429-8D91B118-BD7D-4CA3-A50B-80220C66EBC2Q28535399-F12C43CE-ABB3-4787-9DA4-331DC4510746Q30241069-60B6D6B2-593E-4350-B5F9-F7F93C6D1FCCQ31015478-6F56471F-96B0-47E8-B432-3B54302D83CEQ31077729-2F4B9B09-64D3-4D67-BFFE-E290F4646FE2Q33673940-33ECDC10-A710-430D-82DB-09AC4D1418C2Q33769959-1D7FD994-D88A-4E73-B6DD-3250F356532EQ34072226-9C01F8F3-2535-4EFE-A188-5D4C18DFDF15Q34121467-1385C78C-ADAD-4F35-A70B-09534EFDC71EQ34346725-4E0A397C-ED2B-404C-A89B-CE7ADF4829A9Q34431003-BF436724-8D92-4B3E-AFB2-1C78DEAC508BQ34432197-54A31E05-7E43-4ECA-B3BF-FF174EAB4858Q34999476-EB376C7E-33B8-4DB8-A5AB-6A67099EA33EQ35034863-775FB3B7-991B-4A52-84F6-33A8B6181598Q35061331-B594CB78-B61C-417C-AF11-0229BB7FD46EQ35176105-01D88216-8E8C-4667-84BA-15C2F8B85A91Q35207250-B77BD32A-7F87-4A21-AB1F-59775D43F93EQ35222756-7EADCED0-4053-42EE-882A-0F319E562DC4Q35515702-0DFFAD4E-908B-4E08-8982-9A210EA9623CQ35622435-171B51BD-C1A4-4259-8D57-6A71C8A83871Q35637007-7BD24FD6-C282-4261-954F-6B91D2840C37Q35728840-DEC09292-DA92-42E4-843F-ABC2499CE4B2Q35742631-4D8F2EAC-0A70-4DB8-90A9-9D8C8E76288FQ35793782-6444762F-2E57-490C-9C3E-604FF9D709EFQ35873154-8CEBDF6E-FF56-44BF-8516-B61F2CBB0EB1Q35932960-5D95C311-9C85-4E23-B1CF-871C0EBD42E9Q35947017-57B49F42-8295-43A9-B1C5-1BEF0B8D367DQ35949773-32B26C1F-EB2B-42B8-84BE-F8A05A285449Q36055205-E0623214-40BC-4897-A328-50C03D33B7CCQ36087194-2602E381-005D-4AE5-A7BA-500E77DEDDE7Q36116027-EF578E72-EE2F-430C-BD71-DD84B5901AEEQ36198689-68FDADB2-BCD5-4044-A9D0-AE5EDB728DF9Q36216571-EF5EA45E-8743-4F3D-A4DF-985E34EE3721Q36351953-B615BAB9-2DE3-4039-89A8-50FF0A8FAB02Q36355817-8E326415-C9FA-472D-B22E-356A14E43F67Q36407251-F2EE4D12-1FF7-407A-99CD-4572BE64569B
P2860
Metabolic genes in cancer: their roles in tumor progression and clinical implications
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Metabolic genes in cancer: their roles in tumor progression and clinical implications
@ast
Metabolic genes in cancer: their roles in tumor progression and clinical implications
@en
type
label
Metabolic genes in cancer: their roles in tumor progression and clinical implications
@ast
Metabolic genes in cancer: their roles in tumor progression and clinical implications
@en
prefLabel
Metabolic genes in cancer: their roles in tumor progression and clinical implications
@ast
Metabolic genes in cancer: their roles in tumor progression and clinical implications
@en
P2093
P2860
P1476
Metabolic genes in cancer: their roles in tumor progression and clinical implications
@en
P2093
Aya Kobayashi
Eiji Furuta
Hiroshi Okuda
Kounosuke Watabe
P2860
P304
P356
10.1016/J.BBCAN.2010.01.005
P407
P577
2010-02-01T00:00:00Z